Seite auswählen

The pharmaceutical company Roche was able to increase sales in the first nine months of 2012 compared to the same period last year by 4 percent, assuming constant exchange rates. Expressed in Swiss Francs, the Group actually benefitted from a slightly positive exchange rate effect and reported an increase of 7 percent to CHF 33.69 billion.

The Pharmaceuticals Division posted a sales growth of 7 percent to CHF 26.2 billion. The Diagnostics Division increased sales by 6 percent to CHF 7.5 billion.

Against this background, the management has confirmed its forecast for the full year. In addition, eleven of the 14 projects in late stages of development would have achieved positive results in the first nine months.

[ilink url=“,a2942207,b149.html“] Link zur Quelle (Boerse.Go)[/ilink]